New Diagnostic Score System for Fibromyalgia

New Diagnostic Score System for Fibromyalgia
A study published in The Journal of Rheumatology recently reported a new classification system to assess patients with fibromyalgia. The study is entitled “The Use of Polysymptomatic Distress Categories in the Evaluation of Fibromyalgia (FM) and FM Severity” and was conducted by an international team at the National Data Bank for Rheumatic Diseases and the University of Kansas School of Medicine. Fibromyalgia is a medical disorder characterized by a set of symptoms that includes widespread chronic musculoskeletal pain, incapacitating fatigue, stiffness and numbness in certain parts of the body, painful response to pressure, headaches, unrefreshing sleep (poor sleep quality), anxiety or depression and mood alterations. Fibromyalgia can affect people’s ability to conduct simple daily tasks, compromising their quality of life. It is estimated that 5 to 15 million Americans are affected by this disorder, especially women. The causes of fibromyalgia are unclear, but it is thought that genetic, neurophysiological and psychosocial mechanisms are involved. The polysymptomatic distress (PSD) scale is a tool derived from variables established in the 2010 American College of Rheumatology (ACR) fibromyalgia diagnostic criteria, namely the Widespread Pain Index and the Symptom Severity Scale. The scale allows the
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *